Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10488 | 1059 | 29.8 | 62% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
12 | 4 | POLYMER SCIENCE//MATERIALS SCIENCE, PAPER & WOOD//CHEMISTRY, PHYSICAL | 1084170 |
41 | 3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS//DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//PHARMACOLOGY & PHARMACY | 99449 |
1694 | 2 | MUCOADHESION//THIOMERS//ABSORPTION ENHANCER | 6752 |
10488 | 1 | ABSORPTION ENHANCER//SODIUM CAPRATE//RECTAL ABSORPTION | 1059 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ABSORPTION ENHANCER | authKW | 598479 | 8% | 24% | 85 |
2 | SODIUM CAPRATE | authKW | 397748 | 2% | 53% | 26 |
3 | RECTAL ABSORPTION | authKW | 166323 | 1% | 38% | 15 |
4 | HISTOPATHOL OFF | address | 144163 | 0% | 100% | 5 |
5 | INTESTINAL PERMEATION ENHANCERS | authKW | 141275 | 1% | 70% | 7 |
6 | ORAL HEPARIN | authKW | 129744 | 1% | 75% | 6 |
7 | ORAL DELIVERY | authKW | 121343 | 5% | 8% | 52 |
8 | ZONULA OCCLUDENS TOXIN | authKW | 108538 | 1% | 47% | 8 |
9 | AT1002 | authKW | 102971 | 0% | 71% | 5 |
10 | ABSORPTION PROMOTION | authKW | 86498 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 22031 | 82% | 0% | 869 |
2 | Chemistry, Medicinal | 5812 | 22% | 0% | 236 |
3 | Chemistry, Multidisciplinary | 2515 | 33% | 0% | 346 |
4 | Peripheral Vascular Diseases | 27 | 2% | 0% | 24 |
5 | Medicine, Research & Experimental | 21 | 3% | 0% | 31 |
6 | Hematology | 20 | 2% | 0% | 23 |
7 | Materials Science, Biomaterials | 9 | 1% | 0% | 8 |
8 | Allergy | 3 | 0% | 0% | 5 |
9 | Chemistry, Applied | 1 | 1% | 0% | 12 |
10 | Gastroenterology & Hepatology | 0 | 1% | 0% | 10 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HISTOPATHOL OFF | 144163 | 0% | 100% | 5 |
2 | SIGMOID PHARMA | 64872 | 0% | 75% | 3 |
3 | GASTROINTESTINAL PATHOPHYSIOL SECT | 60062 | 0% | 42% | 5 |
4 | ALZA TECHNOL | 57665 | 0% | 100% | 2 |
5 | FORMULAT DEV 1 | 57665 | 0% | 100% | 2 |
6 | NONCLIN DEV PL BIOL | 57665 | 0% | 100% | 2 |
7 | DRUG ABSORPT PHARMACOKINET | 54298 | 1% | 21% | 9 |
8 | BIOAVAI IL PROJECT | 51896 | 0% | 60% | 3 |
9 | BIOPHARMACEUT YAMASHIMA KU | 43246 | 0% | 50% | 3 |
10 | MED UIJEONGBU ST MARYS HOSP | 38442 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF PHARMACOBIO-DYNAMICS | 42454 | 5% | 3% | 49 |
2 | PHARMACEUTICAL RESEARCH | 25408 | 8% | 1% | 84 |
3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 20796 | 10% | 1% | 107 |
4 | JOURNAL OF PHARMACEUTICAL SCIENCES | 18111 | 8% | 1% | 84 |
5 | JOURNAL OF PHARMACY AND PHARMACOLOGY | 15654 | 6% | 1% | 66 |
6 | CHEMICAL & PHARMACEUTICAL BULLETIN | 13493 | 8% | 1% | 90 |
7 | JOURNAL OF CONTROLLED RELEASE | 7457 | 4% | 1% | 44 |
8 | CRC CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS | 4610 | 0% | 8% | 2 |
9 | DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | 3045 | 2% | 0% | 24 |
10 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2929 | 2% | 1% | 19 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ABSORPTION ENHANCER | 598479 | 8% | 24% | 85 | Search ABSORPTION+ENHANCER | Search ABSORPTION+ENHANCER |
2 | SODIUM CAPRATE | 397748 | 2% | 53% | 26 | Search SODIUM+CAPRATE | Search SODIUM+CAPRATE |
3 | RECTAL ABSORPTION | 166323 | 1% | 38% | 15 | Search RECTAL+ABSORPTION | Search RECTAL+ABSORPTION |
4 | INTESTINAL PERMEATION ENHANCERS | 141275 | 1% | 70% | 7 | Search INTESTINAL+PERMEATION+ENHANCERS | Search INTESTINAL+PERMEATION+ENHANCERS |
5 | ORAL HEPARIN | 129744 | 1% | 75% | 6 | Search ORAL+HEPARIN | Search ORAL+HEPARIN |
6 | ORAL DELIVERY | 121343 | 5% | 8% | 52 | Search ORAL+DELIVERY | Search ORAL+DELIVERY |
7 | ZONULA OCCLUDENS TOXIN | 108538 | 1% | 47% | 8 | Search ZONULA+OCCLUDENS+TOXIN | Search ZONULA+OCCLUDENS+TOXIN |
8 | AT1002 | 102971 | 0% | 71% | 5 | Search AT1002 | Search AT1002 |
9 | ABSORPTION PROMOTION | 86498 | 0% | 100% | 3 | Search ABSORPTION+PROMOTION | Search ABSORPTION+PROMOTION |
10 | BLOOD TOTAL LEUKOCYTE COUNT | 86498 | 0% | 100% | 3 | Search BLOOD+TOTAL+LEUKOCYTE+COUNT | Search BLOOD+TOTAL+LEUKOCYTE+COUNT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MAHER, S , MRSNY, RJ , BRAYDEN, DJ , (2016) INTESTINAL PERMEATION ENHANCERS FOR ORAL PEPTIDE DELIVERY.ADVANCED DRUG DELIVERY REVIEWS. VOL. 106. ISSUE . P. 277 -319 | 233 | 42% | 0 |
2 | MAHER, S , LEONARD, TW , JACOBSEN, J , BRAYDEN, DJ , (2009) SAFETY AND EFFICACY OF SODIUM CAPRATE IN PROMOTING ORAL DRUG ABSORPTION: FROM IN VITRO TO THE CLINIC.ADVANCED DRUG DELIVERY REVIEWS. VOL. 61. ISSUE 15. P. 1427 -1449 | 112 | 50% | 54 |
3 | VANHOOGDALEM, EJ , DEBOER, AG , BREIMER, DD , (1989) INTESTINAL DRUG ABSORPTION ENHANCEMENT - AN OVERVIEW.PHARMACOLOGY & THERAPEUTICS. VOL. 44. ISSUE 3. P. 407-443 | 133 | 58% | 100 |
4 | AUNGST, BJ , (2000) INTESTINAL PERMEATION ENHANCERS.JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 89. ISSUE 4. P. 429-442 | 54 | 66% | 277 |
5 | NISHIHATA, T , RYTTING, JH , (1997) ABSORPTION-PROMOTING ADJUVANTS: ENHANCING ACTION ON RECTAL ABSORPTION.ADVANCED DRUG DELIVERY REVIEWS. VOL. 28. ISSUE 2. P. 205-228 | 49 | 92% | 5 |
6 | MURANISHI, S , (1997) DELIVERY SYSTEM DESIGN FOR IMPROVEMENT OF INTESTINAL ABSORPTION OF PEPTIDE DRUGS.YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN. VOL. 117. ISSUE 7. P. 394 -414 | 40 | 93% | 12 |
7 | PALIWAL, R , PALIWAL, SR , AGRAWAL, GP , VYAS, SP , (2012) RECENT ADVANCES IN SEARCH OF ORAL HEPARIN THERAPEUTICS.MEDICINAL RESEARCH REVIEWS. VOL. 32. ISSUE 2. P. 388-409 | 33 | 58% | 14 |
8 | MAHER, S , WANG, XX , BZIK, V , MCCLEAN, S , BRAYDEN, DJ , (2009) EVALUATION OF INTESTINAL ABSORPTION AND MUCOSAL TOXICITY USING TWO PROMOTERS. II. RAT INSTILLATION AND PERFUSION STUDIES.EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 38. ISSUE 4. P. 301-311 | 38 | 57% | 6 |
9 | ISKENDEROGLU, C , ACARTURK, F , ERDOGAN, D , BARDAKCI, Y , (2013) IN VITRO AND IN VIVO INVESTIGATION OF LOW MOLECULAR WEIGHT HEPARIN-ALGINATE BEADS FOR ORAL ADMINISTRATION.JOURNAL OF DRUG TARGETING. VOL. 21. ISSUE 4. P. 389-406 | 37 | 51% | 2 |
10 | ALAMA, T , KUSAMORI, K , KATSUMI, H , SAKANE, T , YAMAMOTO, A , (2016) ABSORPTION-ENHANCING EFFECTS OF GEMINI SURFACTANT ON THE INTESTINAL ABSORPTION OF POORLY ABSORBED HYDROPHILIC DRUGS INCLUDING PEPTIDE AND PROTEIN DRUGS IN RATS.INTERNATIONAL JOURNAL OF PHARMACEUTICS. VOL. 499. ISSUE 1-2. P. 58 -66 | 25 | 66% | 1 |
Classes with closest relation at Level 1 |